Is RMED or XYLD a better dividend investment in 2026?

RMED currently yields 336.70% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: RMED offers higher current income.

What is the dividend yield difference between RMED and XYLD?

RMED has a forward dividend yield of 336.70% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 325.72 percentage points.

Home › Compare › RMED vs XYLD

RMED vs XYLD: Dividend Comparison 2026

RMED yields 336.70% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RMED wins by $3337.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RMED

● Live price

336.70%

Share price

$0.59

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3337.83M

Annual income

$2,106,889,629.77

Full RMED calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — RMED vs XYLD

📍 RMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RMED	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RMED + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RMED pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMED

Annual income on $10K today (after 15% tax)

$28,619.53/yr

After 10yr DRIP, annual income (after tax)

$1,790,856,185.30/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, RMED beats the other by $1,790,853,449.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMED + XYLD for your $10,000?

RMED: 50%XYLD: 50%

100% XYLD50/50100% RMED

Portfolio after 10yr

$1668.93M

Annual income

$1,053,446,424.40/yr

Blended yield

63.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RMED right now

RMED

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-31.7

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMED buys

XYLD buys

No recent congressional trades found for RMED or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRMEDXYLD

Forward yield	336.70% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3337.83M ✓	$25.3K
Annual income after 10y	$2,106,889,629.77 ✓	$3,219.02
Total dividends collected	$3218.78M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: RMED vs XYLD ($10,000, DRIP)

Year	RMED Portfolio	RMED Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$44,370	$33,670.03	$10,818	$1,098.39	+$33.6K → RMED
2	$187,097	$139,620.61	$11,738	$1,222.51	+$175.4K → RMED
3	$750,420	$550,226.83	$12,774	$1,364.64	+$737.6K → RMED
4	$2,865,463	$2,062,513.01	$13,944	$1,527.86	+$2.85M → RMED
5	$10,426,475	$7,360,429.85	$15,270	$1,715.87	+$10.41M → RMED
6	$36,186,404	$25,030,075.51	$16,775	$1,933.09	+$36.17M → RMED
7	$119,906,417	$81,186,964.99	$18,490	$2,184.87	+$119.89M → RMED
8	$379,719,698	$251,419,831.96	$20,450	$2,477.63	+$379.70M → RMED
9	$1,150,408,903	$744,108,826.12	$22,697	$2,819.19	+$1150.39M → RMED
10	$3,337,827,156	$2,106,889,629.77	$25,280	$3,219.02	+$3337.80M → RMED

RMED vs XYLD: Complete Analysis 2026

RMED — Stock

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Full RMED Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this RMED vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMED vs SCHD RMED vs JEPI RMED vs O RMED vs KO RMED vs MAIN RMED vs QYLD RMED vs JEPQ RMED vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.